Increased numbers of CD5+ B cells in the thymus of estradiol benzoate-treated rats

Thymus. 1996;24(2):111-27.

Abstract

In the present work we combine both flow cytometry and in situ immunohistochemical techniques to study the changes affecting a minor B cell population described within the normal rat thymus, after treatment with estradiol benzoate (EB). Our results, in agreement with previous data, show that the vast majority of these intrathymic B cells are CD5+. The existence of CD5+ B cells was confirmed flow cytometrically in both cervical lymph nodes and spleen of control, adult Wistar rats. Moreover, after EB administration intrathymic B cells increased significantly especially in those rats receiving 500 micrograms of EB, constituting cell masses around the blood vessels of cortico-medullary area and in the thymic medulla. We discuss the significance of this increased number of intrathymic CD5+ B cells, which is probably due to a selective cell migration from the periphery into the thymus, from the view of the effects of estradiol on the thymic vascular permeability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology*
  • CD5 Antigens / analysis*
  • Estradiol / administration & dosage
  • Estradiol / analogs & derivatives*
  • Estradiol / pharmacology
  • Flow Cytometry
  • Immunohistochemistry
  • Lymph Nodes / cytology
  • Lymph Nodes / drug effects
  • Lymphocyte Count / drug effects*
  • Rats
  • Rats, Wistar
  • Spleen / cytology
  • Spleen / drug effects
  • Thymus Gland / cytology
  • Thymus Gland / drug effects*

Substances

  • CD5 Antigens
  • estradiol 3-benzoate
  • Estradiol